Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Double-Blind Randomized Crossover Trial to Define the Electrocardiogram Effects of HPN-100

This study has been completed.
Sponsor:
Information provided by:
Hyperion Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01135680
First received: May 31, 2010
Last updated: November 8, 2010
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given